Provide resuscitation and immediate emergency treatment for children, young people and adults who have convulsive status epilepticus (seizures lasting 5 minutes or more).
Resuscitation
General measures to manage status epilepticus include:
- Positioning the patient to avoid injury
- Securing the airway
- Supporting respiration including the provision of oxygen
- Assessing cardiorespiratory function
- Establishing intravenous access
- Obtaining BM and correcting any hypoglycaemia
- Instituting regular monitoring
- Emergency antiepileptic drug therapy
- Emergency investigations
- Administering glucose and/or intravenous thiamine as high potency intravenous Pabrinex if any suggestion of alcohol abuse or impaired nutrition
- Treating acidosis if severe (discuss with critical care)
- Maintaining blood pressure (with pressor therapy where appropriate)
- Considering and treating underlying cause e.g.
- Medication related (poor compliance, poor absorption, recent antiepileptic drug changes, medication interactions or subtherapeutic levels)
- Infection
- Electrolyte disturbance
- Toxicity or drug withdrawal (including alcohol withdrawal)
- CNS pathology (tumour, stroke, encephalitis, PRES, neurodegenerative diseases etc.)
Emergency antiepileptic drug therapy
- Initial management:
- If the person with convulsive status epilepticus has an individualised emergency management plan that is immediately available, administer medication as detailed in the plan.
- If the person with convulsive status epilepticus does not have an individualised emergency management plan immediately available:
- give a benzodiazepine (buccal midazolam or rectal diazepam) immediately as first-line treatment in the community or
- use intravenous lorazepam if intravenous access and resuscitation facilities are immediately available.
- If convulsive status epilepticus does not respond to the first dose of benzodiazepine:
- Continue to follow the person's individualised emergency management plan, if this is immediately available, or give a second dose of benzodiazepine if the seizure does not stop within 5 to 10 minutes of the first dose.
- If convulsive status epilepticus does not respond to 2 doses of a benzodiazepine, give any of the following medicines intravenously as a second-line treatment:
- levetiracetam (take into account that levetiracetam may be quicker to administer and have fewer adverse effects than the alternative options, although this is an off licence use)
- phenytoin
- sodium valproate
- If convulsive status epilepticus does not respond to a second-line treatment, consider trying an alternative second-line treatment option under expert guidance.
- If convulsive status epilepticus does not respond to the second-line treatment options tried, consider the following third-line options under expert guidance:
- phenobarbital or
- general anaesthesia.
Emergency investigations
- Blood should be taken for blood gases, glucose, renal and liver function, calcium and magnesium, full blood count (including platelets), blood clotting, AED drug levels; 5 ml of serum and 50 ml of urine samples should be saved for future analysis, including toxicology, especially if the cause of the convulsive status epilepticus is uncertain.
- 12 lead ECG.
- Chest radiograph to evaluate possibility of aspiration.
- Other investigations depend on the clinical circumstances and may include brain imaging, lumbar puncture, and EEG.
Monitoring
- Regular neurological observations and measurements of pulse, blood pressure, temperature.
- ECG, biochemistry, blood gases, clotting, blood count, drug levels.
- Patients require the full range of ITU facilities and care should be shared between anaesthetist and neurologist.
- EEG monitoring is necessary for refractory status. Consider the possibility of non-epileptic status. In refractory convulsive status epilepticus, the primary end-point is suppression of epileptic activity on the EEG, with a secondary end-point of burst-suppression pattern (that is, short intervals of up to 1 second between bursts of background rhythm).